Immunology and Microbiology
Hematopoietic Cell
100%
Cell Transplantation
89%
Hematopoietic Stem Cell Transplantation
58%
Graft-Versus-Host Disease
53%
Cord Blood Stem Cell Transplantation
40%
Immune Reconstitution
34%
T Cell
33%
Allogeneic Hematopoietic Stem Cell Transplantation
32%
Anti-Thymocyte Globulin
29%
Overall Survival
29%
Umbilical Cord Blood
22%
Acute Graft Versus Host Disease
18%
Myeloid
17%
Stem Cell
16%
CD4
16%
Conditioning
15%
Arm
14%
Engraftment
14%
Drug Megadose
12%
Organoid
12%
Intestinal Stem Cell
11%
Immunity
11%
T-Helper Cell
11%
B Cell
10%
Human Respiratory Syncytial Virus
10%
Immune Response
8%
Neutrophil
8%
Cytomegalovirus
8%
Natural Killer Cell
8%
Chronic Graft Versus Host Disease
8%
Autoimmune Disease
7%
Event Free Survival
7%
Eosinophil
7%
Eosinophil Granulocyte
7%
Lower Respiratory Tract
7%
Mesenchymal Stem Cell
7%
Granulocyte
6%
STAT1
6%
Virus Detection
6%
Allogeneic Stem Cell Transplantation
6%
Primary Immunodeficiency
6%
Hemophagocytic Lymphohistiocytosis
5%
interferon
5%
Rituximab
5%
Bone Marrow Transplantation
5%
Immunosuppression
5%
CD34
5%
Severe Combined Immunodeficiency
5%
Immunocompetent Cell
5%
Adenoviridae
5%
Keyphrases
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
84%
Hematopoietic Cell Transplantation
67%
Graft-versus-host Disease (GvHD)
64%
Hematopoietic Stem Cell Transplantation
42%
Pediatric
38%
Cord Blood Transplantation
32%
Immune Reconstitution
30%
Antithymocyte Globulin
29%
Metachromatic Leukodystrophy
21%
Overall Survival
20%
Pediatric Patients
20%
Immune Response
17%
T Cells
16%
Fludarabine
15%
Transplantation
14%
Clinical Outcomes
13%
Reconstitution
13%
Umbilical Cord Blood
13%
Confidence Interval
12%
Therapeutic Drug Monitoring
12%
Hazard Ratio
12%
Busulfan
12%
Virus
11%
Cord Blood
11%
Respiratory Syncytial Virus
10%
Marrow Transplantation
10%
Graft Failure
10%
Conditioning Regimen
10%
High Risk
10%
Hematological Malignancies
9%
Invasive Fungal Infection
9%
Event-free Survival
9%
Outcome Prediction
9%
Acute Leukemia
9%
Allogeneic HSCT
9%
Engraftment
9%
Bloodstream Infection
9%
Risk Factors
8%
Myeloablative
8%
Eosinophils
8%
Non-relapse Mortality
8%
Transplant Outcomes
8%
Transplant Recipients
8%
Apoptosis
7%
Adenovirus
7%
Acute Lymphoblastic Leukemia
7%
CD4+ T
7%
Intestinal Injury
7%
Clofarabine
7%
Natural Killer Cells
7%
Medicine and Dentistry
Hematopoietic Cell
70%
Cell Transplantation
54%
Hematopoietic Stem Cell Transplantation
47%
Pediatrics
36%
Metachromatic Leukodystrophy
30%
Transplantation
25%
Cord Blood
20%
Allogeneic Hematopoietic Stem Cell Transplantation
20%
Immune Reconstitution
20%
Cord Blood Stem Cell Transplantation
19%
Graft Versus Host Reaction
17%
Disease
16%
Pediatrics Patient
15%
T Cell
13%
Overall Survival
11%
Hazard Ratio
10%
Leukemia
9%
Infection
9%
Chronic Graft Versus Host Disease
9%
B Cell
8%
Acute Graft Versus Host Disease
8%
Cytomegalovirus
8%
Graft Failure
8%
Lung
8%
Immunity
7%
Acute Lymphoblastic Leukemia
7%
Thymocyte Antibody
7%
Busulfan
7%
Conditioning
7%
Systemic Mycosis
6%
Adenoviridae
6%
Infectious Complication
6%
Allogeneic Stem Cell Transplantation
6%
Acute Myeloid Leukemia
6%
Organoid
6%
Cell Therapy
6%
Adrenoleukodystrophy
6%
Bloodstream Infection
6%
Interferon
6%
Intestinal Stem Cell
6%
Meta-Analysis
6%
Polyneuropathy
6%
Systematic Review
6%
Stem Cell
6%
Hematologic Malignancy
5%
Cytopenia
5%
Cumulative Incidence
5%